Tuberous Sclerosis Alliance to honor CVS Health's Helena Foulkes

SILVER SPRING, Md. — The Tuberous Sclerosis Alliance will honor Helena Foulkes, president of CVS/pharmacy and EVP of CVS Health, at the organization's 14th Annual Comedy for a Cure in April.



The event will take place on April 12 at the Globe Theater in Universal City, Calif. Over the past 13 years, this event has raised nearly $4 million to support TS Alliance research efforts and support programs for people with tuberous sclerosis complex.



CVS Health first got involved in Comedy for a Cure in 2005 and has continued to support the event through generous sponsorships.

"Helena has served on the honorary committee of Comedy for a Cure since 2012 and has been instrumental in TS Alliance government advocacy efforts by garnering Congressional support for the appropriation for TSC research in the Congressionally Directed Medical Research Program budget," stated Kari Luther Rosbeck, TS Alliance president and CEO.



In addition, since FDA approval of Sabril (vigabatrin) in 2009, CVS Health has served as one-of-four specialty pharmacies that distribute the medication based on very strict safety requirements.



"Under Helena's leadership, CVS Health has gone above and beyond to ensure the needs of children and adults with TSC are met through timely medication delivery and by working tirelessly with the TSC community and insurance companies to mediate any issues with coverage," Rosbeck stated.



TSC is a multisystem genetic disorder that causes tumors to form in vital organs, primarily the brain, heart, eyes, kidneys, lungs and skin. It is also the leading genetic cause of both autism and epilepsy. Approximately 50,000 people in the United States suffer from the disease, and it has an estimated incidence of one in 6,000 live births. More than 1 million people worldwide have TSC.